E-LIB Suche - Ergebnisse für: Geurts-Moespot, A.

1

Mucosal lactoferrin response to genital tract infections is..:

Roberts, S. A. ; Brabin, L. ; Diallo, S....
European Journal of Clinical Nutrition. 73 (2019) 11 - p. 1464-1472 , 2019

Link: https://doi.org/10.1038/..

2

Determination of ASCO recommended prognostic factors uPA an..:

, In: 31st Annual San Antonio Breast Cancer Symposium

Thomssen, C. ; Vetter, M. ; Geurts-Moespot, A..... (2009) 2 - p. 133

Copies: Zentrale: z med 900 jc/01-69,12

3

0069 Prognostic factors upa and PAI-1: Feasibility and vali..:

Vetter, M. ; Lantzsch, T. ; Abraha-Späth, S....
The Breast. 18 (2009) - p. S35 , 2009

Link: https://doi.org/10.1016/..

4

0058 Determination of ASCO recommended prognostic factors u..:

Thomssen, C. ; Vetter, M. ; Kantelhardt, E....
The Breast. 18 (2009) - p. S32 , 2009

Link: https://doi.org/10.1016/..

5

A decrease of plasma macrophage migration inhibitory factor..:

DE MAST, Q. ; SWEEP, F. C. G. J. ; McCALL, M....
Parasite Immunology. 30 (2008) 3 - p. 133-138 , 2008

Link: https://doi.org/10.1111/..

6

External and internal assurance of the determination of the..:

Vetter, M. ; Geurts-Moespot, A. ; Kantelhardt, E.J....
European Journal of Cancer Supplements. 6 (2008) 7 - p. 192 , 2008

Link: https://doi.org/10.1016/..

7

Development of ELISAs for Quantification of HMFG1-Specific ..:

Oei, A.L.M. ; Boerman, O.C. ; Geurts-Moespot, A....
The International Journal of Biological Markers. 22 (2007) 3 - p. 167-171 , 2007

Link: https://doi.org/10.1177/..

8

Association between High Levels of Blood Macrophage Migrati..:

Emonts, M. ; Sweep, F. C. G. J. ; Grebenchtchikov, N....
Clinical Infectious Diseases. 44 (2007) 10 - p. 1321-1328 , 2007

Link: https://doi.org/10.1086/..

9

237 Investigation of plasminogen activator inhibitor-1 (PAI..:

Schilling, D. ; Sprague, L. ; Geurts-Moespot, A...
Radiotherapy and Oncology. 78 (2006) - p. S84 , 2006

Link: https://doi.org/10.1016/..

10

CSF levels of growth factors and plasminogen activators in ..:

van de Langerijt, B. ; Gijtenbeek, J. M. ; de Reus, H.P.M....
Neurology. 67 (2006) 1 - p. 114-119 , 2006

Link: https://doi.org/10.1212/..

11

CSF levels of angiogenesis-related proteins in patients wit..:

Reijneveld, J. C. ; Brandsma, D. ; Boogerd, W....
Neurology. 65 (2005) 7 - p. 1120-1122 , 2005

Link: https://doi.org/10.1212/..

12

High Levels of Urinary Vascular Endothelial Growth Factor i..:

Roes, E.M. ; Steegers, E.A.P. ; Thomas, C.M.G....
The International Journal of Biological Markers. 19 (2004) 1 - p. 72-75 , 2004

Link: https://doi.org/10.1177/..

13

The complex between urokinase plasminogen activator (uPA) a..:

Manders, P ; Beex, L ; Tjan-Heijnen, V...
European Journal of Cancer Supplements. 2 (2004) 3 - p. 173 , 2004

Link: https://doi.org/10.1016/..

14

An ELISA avoiding interference by heterophilic antibodies i..:

Grebenchtchikov, N ; Sweep, C.G.J ; Geurts-Moespot, A...
Journal of Immunological Methods. 268 (2002) 2 - p. 219-231 , 2002

Link: https://doi.org/10.1016/..

15

Prognostic impact of urokinase-type plasminogen activator r..:

Witte, J H de ; Foekens, J A ; Brünner, N...
British Journal of Cancer. 85 (2001) 1 - p. 85-92 , 2001

Link: https://doi.org/10.1054/..